Biopharma scientists — particularly those with published research in high-impact journals, patent portfolios, NIH or industry grants, and peer review committee memberships — often meet multiple EB-1A criteria simultaneously. The critical challenge is ensuring that USCIS adjudicators understand the significance of your contributions in a domain they may not be familiar with. Silmi Law writes petitions that explain the scientific weight of your achievements in clear, compelling terms.
Employer Sponsor Required
Petition Filed
Criteria Required
Preference Priority
We assess publications, patents, regulatory dossiers, grants, and peer recognition across your career.
We write the petition letter in language that bridges your scientific expertise with USCIS evidentiary standards.
We write the petition letter in language that bridges your scientific expertise with USCIS evidentiary standards.
We file the petition and provide detailed responses to any USCIS requests for additional evidence.
We understand how to frame clinical trial leadership, drug discovery contributions, and published research within USCIS EB-1A standards.
We translate peer-reviewed papers, patent portfolios, and FDA regulatory submissions into compelling evidentiary exhibits.
Sharif Silmi personally leads every biopharma EB-1A petition — no handoffs to junior staff.
We serve both bench scientists and clinical researchers, including principal investigators, medical directors, and regulatory affairs leaders
NIH R01 grants, BARDA awards, and pharmaceutical industry prizes are documented precisely within the USCIS criteria framework.
We serve biopharma scientists across the Bay Area, New Jersey/Philadelphia corridor, Boston, and New York.
